Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

BURNABY, British Columbia, Feb. 14, 2022 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced its participation in one-on-one investor meetings and a... | February 14, 2022

Related Keywords

United Kingdom ,British ,Ian Mortimer ,Jodi Regts ,Xenon Pharmaceuticals Inc ,Nasdaq ,Globenewswire Inc ,British Columbia ,Global Healthcare ,Chat Details ,Media Contact ,Xenon Pharmaceuticals Inc Stock Exchange ,News ,Information ,Press Release ,022 ,Lenon ,Pharmaceuticals ,Iopharmaceutical ,Oday ,Nnounced ,Its ,Participation ,N ,Investor ,Meetings ,Nd Xene Ca98420n1050 ,